An exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
Study identifier:TC-1734-226-CRD-005
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
An exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
Medical condition
ADHD
Phase
Phase 2
Healthy volunteers
No
Study drug
Placebo, AZD3480
Sex
All
Actual Enrollment
45
Study type
Interventional
Age
18 Years - 65 Years
Date
Study Start Date: 01 May 2008
Primary Completion Date: 01 Apr 2009
Study Completion Date: 01 Apr 2009
Study design
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Double Blind
Primary Purpose: Treatment
Verification:
Verified 01 Jul 2014 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
Targacept Inc.
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Placebo Comparator: 1 | Drug: Placebo Placebo |
| Experimental: 2 | Drug: AZD3480 Capsules 5 mg/day (once a day) for 2 weeks Other Name: AZD3480 |
| Experimental: 3 | Drug: AZD3480 Capsules 50 mg/day (once a day) for 2 weeks Other Name: AZD3480 |
